RevMed

Adventure Ready Brands 0120-0203 Adventure Medical Kits

Company Name
Adventure Ready Brands
Catalog Number
0120-0203

Description

Adventure First Aid, 0.5 TinSurvival Tools1 - Slim Rescue Howler™ WhistleBandage Materials5 - Easy Access Bandages®, 1" x 3" Fabric1 - Easy Access Bandages®, Elbow/Knee Fabric2 - Butterfly Closure Fabric Adhesive BandageBlister / Burn14 - Moleskin, Pre-Cut & Shaped PiecesInstrument3 - Safety Pins1 - Splinter Picker / Tick Remover ForcepsMedication2 - Insect Sting Relief PadWound Care3 - Antiseptic Wipe2 - Alcohol Swab2 - Triple Antibiotic Ointment
Have questions or need more information? Contact Us

Pricing
Summary

Price Not Available
Out of Stock
Interested in this product?
Contact us or login to add to your watchlist.

Related Items

-

RESONANCE HEALTH ANALYSIS SERVICES PTY LTD - HepaFatSmart

Standalone software as medical device (SaMD) designed to automatically analyse within seconds magnetic resonance imaging (MRI) datasets to generate an estimate of the patient’s volumetric liver fat fraction (VLFF), converted into proton density fat fraction (PDFF) and steatosis grade. No user input is required for the analysis thus minimising the impact of human error on obtained results. HepaFatSmart is intended for the quantitative evaluation of volumetric liver fat fraction (VLFF), proton density fat fraction (PDFF) and liver steatosis grading.It utilises magnetic resonance images that exploit the difference in resonance frequencies between hydrogen nuclei in water and triglyceride fat. The quantitative triglyceride fat fraction is based on the measurement of a magnetic resonance parameter that reflects the ratio of the proton density signal of triglyceride fat to the total proton density signal in the liver.When interpreted by a trained physician, the results provide information that can aid in diagnosis.HepaFatSmart is indicated to:• Support clinical diagnoses in individuals with confirmed or suspected fatty liver disease; • Assessment of liver fat content to support the subsequent clinical decision-making processes for patients under management of diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), viral hepatitis. • Support the subsequent clinical decision-making processes for patients Results, when interpreted by a trained physician can be used to support clinical diagnoses about the status of liver fat content, the subsequent clinical decision-making processes for the management of fatty liver related diseases.
Out of Stock
Radiology

Additional Details

Device Identifier
00707708102035
Is RX
No
Is Over the Counter
Yes
Requires Sterilization
No
Is Sterile
No
Is Single Use
No

Barcode Mapping

Unit of MeasurementEachesGTIN
Each100707708102035